相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2008)
Epigenetics of cancer progression
Emily A. Vucic et al.
PHARMACOGENOMICS (2008)
Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma
Waka Sugawara et al.
PEDIATRIC BLOOD & CANCER (2007)
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller
HUMAN MOLECULAR GENETICS (2007)
Quantitative evaluation of RASSFIA methylation in the non-lesional, regenerative and neoplastic liver
Sonia Di Gioia et al.
BMC CANCER (2006)
Epigenetic silencing of the MGMT gene in cancer
H Soejima et al.
BIOCHEMISTRY AND CELL BIOLOGY (2005)
Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma
YJ Zhang et al.
CANCER LETTERS (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Hepatocellular carcinoma: Recent trends in the United States
HB El-Serag
GASTROENTEROLOGY (2004)
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
JA Davila et al.
GASTROENTEROLOGY (2004)
Epigenetic inactivation of CHFR in human tumors
M Toyota et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis
J Yu et al.
BMC CANCER (2002)
Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer
Y Shibata et al.
CARCINOGENESIS (2002)
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers
K Mizuno et al.
ONCOGENE (2002)
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
DG Burbee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
A Agathanggelou et al.
ONCOGENE (2001)
Chfr defines a mitotic stress checkpoint that delays entry into metaphase
DM Scolnick et al.
NATURE (2000)
分享论文
